Conversely, inhibiting both PI3K/Akt and SHH pathways results in tumour apoptosis and reduced growth of PTEN-deficient GBMs in experimental models, underscoring the crosstalk between these pathways [127]. The gene discussed is SHH; the disease is neoplasm.